Search clinical trials for: ELOVL2
Total 1 results
-
HKGepitherapeuticsWithdrawn
Sponsors and Collaborators
- Korea Otsuka International Asia Arab
- Plethora Solutions Ltd
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Oblikue Consulting
- Eurotrials Brasil Consultores Cientificos Ltda
- Julian Taylor Green
- United States Department of Defense (DOD)
- S-Biotek Holding ApS
- University of Applied Sciences Jena
- Arsha Vidya Tirtha
- Rivierduinen, Centre for Personality disorders Jelgersma
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Gunkang Pharmaceuticals, Inc
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Foshan Sanshui District People's Hospital
- Sudimplant SAS - Groupe TBR
- Lilly PharmaceuticalCompany
- Paulo Sérgio Gomes Nogueira Borges
- Iyad Naeem Muhammad, PhD
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- View Full List
Medical Conditions
- Huntington Chorea
- Testicular Teratoma
- Malaria,Falciparum
- Gray Platelet Syndrome
- Serum Albumin Low
- Immunologically-induced Lung Disease
- Hypothermia Following Anesthesia, Sequela
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Advance Directive Completion
- Puberty, Delayed
- Brain Tumor, Primary
- Thyroid and Parathyroid Surgery
- Chemotherapy-Induced Neutropenia
- Deformity Flexion
- Vibration; Exposure
- Visual Attention Span Deficit
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Anemia Acute
- Blepharospasm of Both Eyelids
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- View Full List
Drug Interventions
- Cytisine
- Celecoxib
- Standard medical therapy
- Pegfilgrastim
- ABY-035 i.v.
- Ebselen
- S-Adenosyl-Methionine
- F520
- Mineralocorticoid receptor antagonist
- Furmonertinib 160 mg
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- MMV390048 120mg
- Rovalpituzumab tesirine
- Vosaroxin
- Pemetrexed
- Sorafenib
- Bimatoprost 0.03% eye drops
- Acalabrutinib in combination with VR
- Oxycodone
- Cyanoacrylate
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Congo
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Germany
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Moldova
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Suriname
- Contract Research Organizations in Togo
- Contract Research Organizations in Uzbekistan
- CRO list by country